Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer

BACKGROUND: The lung immune prognostic index (LIPI) is a marker that combines the derived neutrophil‐to‐lymphocyte ratio (dNLR) and serum lactate dehydrogenase (LDH) level and is a recently reported prognostic factor of immune checkpoint inhibitor therapy for non‐small cell lung cancer (NSCLC). Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonehara, Kei, Tateishi, Kazunari, Komatsu, Masamichi, Yamamoto, Hiroshi, Hanaoka, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262905/
https://www.ncbi.nlm.nih.gov/pubmed/32286017
http://dx.doi.org/10.1111/1759-7714.13432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262905/
https://www.ncbi.nlm.nih.gov/pubmed/32286017
http://dx.doi.org/10.1111/1759-7714.13432

Ejemplares similares